Skip to main content

Table 3 Maternal Condition in The Third Trimester, According to Study Group

From: Maternal and infant outcomes during the COVID-19 pandemic: a retrospective study in Guangzhou, China

Maternal condition 24 January – 31 March 2020
(n = 589)
24 January – 31 March 2019
(n = 733)
P Value
Gestational diabetes
WhiteA1 39/589(6.62) 66/733(9.00) 0.11
WhiteA2 10/589(1.70) 20/733(2.73) 0.21
Pregnancy with obesity 62/589(10.53) 69/733(9.41) 0.50
Hepatitis B 37/589(6.28) 51/733(6.96) 0.63
PCOS 1/589(0.17) 1/733(0.14) 1.00
Scarred uterus 97/589(16.47) 128/733(17.46) 0.63
Uterine fibroids 22/589(3.74) 32/733(4.37) 0.56
Preeclampsia 2/589(0.34) 7/733(0.95) 0.31
Placenta implantation 2/589(0.34) 2/733(0.27) 1.00
Placenta previa 5/589(0.85) 5/733(0.68) 0.73
Vaginitis 18/589(3.06) 26/733(3.55) 0.62
BGS infection 5/589(0.85) 7/733(0.95) 0.84
Hypothyroidism 25/589(4.24) 29/733(3.96) 0.79
Pregnancy with thrombocytopenia 2/589(0.34) 2/733(0.27) 1.00
ICP 11/589(1.87) 12/733(1.64) 0.75
  1. Differences between the groups were compared with the chi-square test or Fisher’s exact test. PCOS: Polycystic ovary syndrome, ICP: Intrahepatic cholestasis of pregnancy